" class="no-js "lang="en-US"> Industry News Archives - Page 7 of 151 - Medtech Alert
Friday, October 03, 2025

Sort by:

Date

Top Post

ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients

ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]

HuidaGene Therapeutics Appoints Alvin Luk as Chief Executive Officer

HuidaGene Therapeutics, a clinical-stage genome-editing company, today announced the appointment of gene therapy industry veteran, […]

Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials

Endo International announced today that its subsidiary Endo Ventures has executed an agreement with MAIA […]

ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth

ElevateBio, a technology-driven company focused on powering the creation of life-transforming cell and gene therapies, […]

Bob Battista Joins Platform Life Sciences as EVP, Chief Strategy & Commercial Officer

Platform Life Sciences, a global impact research organization, has announced the appointment of Bob Battista as […]

Obsidian Therapeutics Announces Dr. Madan Jagasia as Chief Executive Officer and Other Leadership Appointments

Obsidian Therapeutics, a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced the […]

Life Biosciences Expands Team with the Appointment of Ming Yang, Ph.D., as SVP of Research and Development

Life Biosciences (“Life Bio”), a biotechnology company advancing innovative cellular rejuvenation platforms to reverse diseases […]

smartbax Announces Seed Financing of €1.2 Million to Develop Next-generation Antibiotics

smartbax, a biotech company developing next-generation antibiotics against multi-drug resistant bacteria, today announced the close […]

Gamida Cell Appoints Terry Coelho as CFO

Gamida Cell, a cell therapy pioneer working to turn cells into powerful therapeutics, has announced […]

Nona Biosciences Enters into Antibody Discovery Agreement with OPKO Health's ModeX Therapeutics

Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited, committed to cutting-edge antibody technology innovation […]

Food and Drug Administration (FDA) and Clarivate Extend Material Transfer Agreement for Three Additional Years

Clarivate, a global leader in connecting people and organizations to intelligence they can trust to […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more